ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 519 | -16.2% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 619 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | – | 619 | +519.0% | 0.00% | – |
Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 100 | -84.1% | 0.00% | – |
Q3 2017 | $3,000 | -93.0% | 630 | -93.2% | 0.00% | -100.0% |
Q2 2017 | $43,000 | +1333.3% | 9,290 | +1374.6% | 0.00% | – |
Q1 2017 | $3,000 | 0.0% | 630 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | -25.0% | 630 | +18.9% | 0.00% | – |
Q3 2016 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | 0.0% | 530 | +60.6% | 0.00% | – |
Q4 2015 | $4,000 | – | 330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,733,815 | $81,081,000 | 11.64% |
RTW INVESTMENTS, LP | 2,589,818 | $17,896,000 | 5.56% |
DAFNA Capital Management LLC | 480,300 | $3,319,000 | 3.29% |
DOHENY ASSET MANAGEMENT /CA | 510,125 | $3,525,000 | 1.83% |
Sio Capital Management, LLC | 364,368 | $2,518,000 | 1.73% |
TURNER INVESTMENTS LLC | 1,086,000 | $7,504,000 | 1.52% |
Ghost Tree Capital, LLC | 300,000 | $2,073,000 | 0.93% |
Rock Springs Capital Management LP | 1,125,000 | $7,774,000 | 0.63% |
SENZAR ASSET MANAGEMENT, LLC | 619,000 | $4,277,290,000 | 0.62% |
Point72 Asset Management, L.P. | 9,772,018 | $67,525,000 | 0.53% |